CLINICAL STUDY: HEART FAILURE
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?
Armin Zittermann, PhD*,*,
Stefanie Schulze Schleithoff*,
Gero Tenderich, MD ,
Heiner K. Berthold, MD, PhD ,
Reiner Körfer, MD and
Peter Stehle, PhD*
* Department of Nutrition Science, University of Bonn, Germany
Heart and Diabetes Center North Rhine-Westfalia, Department of Thoracic and Cardiovascular Surgery, Ruhr-University of Bochum, Bad Oeynhausen, Germany
Center for Cardiovascular Diseases, Department Clinical Pharmacology, Rotenburg a.d. Fulda, Germany
Manuscript received January 25, 2002;
revised manuscript received August 19, 2002,
accepted September 13, 2002.
* Reprint requests and correspondence: Dr. Armin Zittermann, Associate Professor, Department of Nutrition Science, University of Bonn, Endenicher Allee 11-13, 53115 Bonn, Germany. a.zittermann{at}uni-bonn.de
OBJECTIVES: This study was designed to evaluate the association between vitamin D status and congestive heart failure (CHF).
BACKGROUND: Impaired intracellular calcium metabolism is an important factor in the pathogenesis of CHF. The etiology of CHF, however, is not well understood.
METHODS: Twenty patients age <50 years and 34 patients age 50 years with New York Heart Association classes 2 and 34 control subjects age 50 years were recruited. N-terminal pro-atrial natriuretic peptide (NT-proANP), a predictor of CHF severity; vitamin D metabolites; and parameters of calcium metabolism were measured in fasting blood samples collected between November 2000 and March 2001.
RESULTS: Both groups of CHF patients had markedly increased serum levels of NT-proANP (p < 0.001), increased serum phosphorus levels (p < 0.001), and reduced circulating levels of both 25-hydroxyvitamin D (p < 0.001) and calcitriol (p < 0.001). Albumin-corrected calcium levels were reduced and parathyroid hormone levels were increased in the younger CHF patients compared with the controls (both p values <0.001). Moreover, parathyroid hormone levels tended to be higher in the elderly CHF patients than in the controls (p = 0.074). In a nonlinear regression analysis 25-hydroxyvitamin D and calcitriol were inversely correlated with NT-proANP (r2 = 0.16; p < 0.001 and r2 = 0.12; p < 0.01, respectively). The vitamin D genotype at the BmsI restriction site did not differ between the study groups.
CONCLUSIONS: The low vitamin D status can explain alterations in mineral metabolism as well as myocardial dysfunction in the CHF patients, and it may therefore be a contributing factor in the pathogenesis of CHF.
|
Abbreviations and Acronyms
| | Ca2+ | | ionized calcium | | CHF | | congestive heart failure | | CI | | cardiac index | | LVEF | | left ventricular ejection fraction | | NT-proANP | | N-terminal pro-ANP | | NYHA | | New York Heart Association | | 25OHD | | 25-hydroxyvitamin D | | PCWP | | pulmonary wedge pressure | | PTH | | parathyroid hormone | | TNF | | tumor necrosis factor | | UV | | ultraviolet | | VDR | | vitamin D receptor |
|
This article has been cited by other articles:

|
 |

|
 |
 
C J Ferro, C D Chue, R P Steeds, and J N Townend
Is lowering phosphate exposure the key to preventing arterial stiffening with age?
Heart,
November 1, 2009;
95(21):
1770 - 1772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Soukoulis, J. B. Dihu, M. Sole, S. D. Anker, J. Cleland, G. C. Fonarow, M. Metra, E. Pasini, T. Strzelczyk, H. Taegtmeyer, et al.
Micronutrient deficiencies an unmet need in heart failure.
J. Am. Coll. Cardiol.,
October 27, 2009;
54(18):
1660 - 1673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kilkkinen, P. Knekt, A. Aro, H. Rissanen, J. Marniemi, M. Heliovaara, O. Impivaara, and A. Reunanen
Vitamin D Status and the Risk of Cardiovascular Disease Death
Am. J. Epidemiol.,
October 15, 2009;
170(8):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Mowry, M. M. Costello, and K. A. Heelan
Association Among Cardiorespiratory Fitness, Body Fat, and Bone Marker Measurements in Healthy Young Females
J Am Osteopath Assoc,
October 1, 2009;
109(10):
534 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Reis, D. von Muhlen, E. R. Miller III, E. D. Michos, and L. J. Appel
Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population
Pediatrics,
September 1, 2009;
124(3):
e371 - e379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Covic, P. Kothawala, M. Bernal, S. Robbins, A. Chalian, and D. Goldsmith
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
Nephrol. Dial. Transplant.,
May 1, 2009;
24(5):
1506 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tastan, R. Schreckenberg, S. Mufti, Y. Abdallah, H. M. Piper, and K.-D. Schluter
Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way
Cardiovasc Res,
April 1, 2009;
82(1):
77 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Weber, W. B. Weglicki, and R. U. Simpson
Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium
Cardiovasc Res,
February 15, 2009;
81(3):
500 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Nephrol. Dial. Transplant.,
February 1, 2009;
24(2):
611 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Foley, A. J. Collins, C. A. Herzog, A. Ishani, and P. A. Kalra
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
397 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y.-M. Wang, J. E Sanderson, M. Wang, S.-F. Lui, M. M.-M. Sea, J. Woo, C. W.-K. Lam, and I. H.-S. Chan
Reply to C Fourtounas and JG Vlachojannis
Am. J. Clinical Nutrition,
January 1, 2009;
89(1):
436 - 438.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Reis, E. D Michos, D. von Muhlen, and E. R Miller III
Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease
Am. J. Clinical Nutrition,
December 1, 2008;
88(6):
1469 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. van Diepen, S. R. Majumdar, J. A. Bakal, F. A. McAlister, and J. A. Ezekowitz
Heart Failure Is a Risk Factor for Orthopedic Fracture: A Population-Based Analysis of 16 294 Patients
Circulation,
November 4, 2008;
118(19):
1946 - 1952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pilz, W. Marz, B. Wellnitz, U. Seelhorst, A. Fahrleitner-Pammer, H. P. Dimai, B. O. Boehm, and H. Dobnig
Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography
J. Clin. Endocrinol. Metab.,
October 1, 2008;
93(10):
3927 - 3935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Wallis, S. Penckofer, and G. W. Sizemore
The "Sunshine Deficit" and Cardiovascular Disease
Circulation,
September 30, 2008;
118(14):
1476 - 1485.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Melamed, E. D. Michos, W. Post, and B. Astor
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Arch Intern Med,
August 11, 2008;
168(15):
1629 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Pai and T. A. Conner
Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D
Journal of Pharmacy Practice,
June 1, 2008;
21(3):
214 - 224.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Melamed, P. Muntner, E. D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004
Arterioscler Thromb Vasc Biol,
June 1, 2008;
28(6):
1179 - 1185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T Weber, R. U Simpson, and L. D Carbone
Vitamin D and calcium dyshomoeostasis-associated heart failure
Heart,
May 1, 2008;
94(5):
540 - 541.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zittermann, S. S. Schleithoff, C. Gotting, O. Dronow, U. Fuchs, J. Kuhn, K. Kleesiek, G. Tenderich, and R. Koerfer
Poor outcome in end-stage heart failure patients with low circulating calcitriol levels
Eur J Heart Fail,
March 1, 2008;
10(3):
321 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan
Vitamin D Deficiency and Risk of Cardiovascular Disease
Circulation,
January 29, 2008;
117(4):
503 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chonchol, M. Cigolini, and G. Targher
Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction
Nephrol. Dial. Transplant.,
January 1, 2008;
23(1):
269 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Alsafwah, S. P. LaGuardia, M. Arroyo, B. K. Dockery, S. K. Bhattacharya, R. A. Ahokas, and K. P. Newman
Congestive Heart Failure is a Systemic Illness: A Role for Minerals and Micronutrients
Clin. Med. Res.,
December 1, 2007;
5(4):
238 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bodyak, J. C. Ayus, S. Achinger, V. Shivalingappa, Q. Ke, Y.-S. Chen, D. L. Rigor, I. Stillman, H. Tamez, P. E. Kroeger, et al.
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals
PNAS,
October 23, 2007;
104(43):
16810 - 16815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Holick
Vitamin D Deficiency
N. Engl. J. Med.,
July 19, 2007;
357(3):
266 - 281.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Martins, M. Wolf, D. Pan, A. Zadshir, N. Tareen, R. Thadhani, A. Felsenfeld, B. Levine, R. Mehrotra, and K. Norris
Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States: Data From the Third National Health and Nutrition Examination Survey
Arch Intern Med,
June 11, 2007;
167(11):
1159 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dhingra, L. M. Sullivan, C. S. Fox, T. J. Wang, R. B. D'Agostino Sr, J. M. Gaziano, and R. S. Vasan
Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community
Arch Intern Med,
May 14, 2007;
167(9):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schwalfenberg
Not enough vitamin D: Health consequences for Canadians
Can Fam Physician,
May 1, 2007;
53(5):
841 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Michos and R. S. Blumenthal
Vitamin D Supplementation and Cardiovascular Disease Risk
Circulation,
February 20, 2007;
115(7):
827 - 828.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. London, A. P. Guerin, F. H. Verbeke, B. Pannier, P. Boutouyrie, S. J. Marchais, and F. Metivier
Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency
J. Am. Soc. Nephrol.,
February 1, 2007;
18(2):
613 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Saadi, E. Kazzam, B. A. Ghurbana, and M. G. Nicholls
Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure
Eur J Heart Fail,
November 1, 2006;
8(7):
694 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun, R. A. Ahokas, S. K. Bhattacharya, I. C. Gerling, L. D. Carbone, and K. T. Weber
Oxidative stress in aldosteronism
Cardiovasc Res,
July 15, 2006;
71(2):
300 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S Schleithoff, A. Zittermann, G. Tenderich, H. K Berthold, P. Stehle, and R. Koerfer
Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.
Am. J. Clinical Nutrition,
April 1, 2006;
83(4):
754 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Holick
High Prevalence of Vitamin D Inadequacy and Implications for Health
Mayo Clin. Proc.,
March 1, 2006;
81(3):
353 - 373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick
The Role of Vitamin D in Cancer Prevention
Am J Public Health,
February 1, 2006;
96(2):
252 - 261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Holick
The Vitamin D Epidemic and its Health Consequences
J. Nutr.,
November 1, 2005;
135(11):
2739S - 2748S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan, and for the Cholesterol And Recurrent Events (CARE) Tr
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Circulation,
October 25, 2005;
112(17):
2627 - 2633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Law, Y. Sun, S. K. Bhattacharya, V. S. Chhokar, and K. T. Weber
Diuretics and Bone Loss in Rats With Aldosteronism
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
142 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vieth, R. Scragg, P.E. Norman, and J.T. Powell
Vitamin D Nutrition Does Not Cause Peripheral Artery Disease
Arterioscler Thromb Vasc Biol,
May 1, 2005;
25(5):
e41 - e42.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Teng, M. Wolf, M. N. Ofsthun, J. M. Lazarus, M. A. Hernan, C. A. Camargo Jr, and R. Thadhani
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
J. Am. Soc. Nephrol.,
April 1, 2005;
16(4):
1115 - 1125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Chhokar, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, L. K. Myers, Z. Xing, R. A. Smith, I. C. Gerling, and K. T. Weber
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Circulation,
February 22, 2005;
111(7):
871 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Chhokar, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, L. K. Myers, Z. Xing, R. A. Smith, I. C. Gerling, and K. T. Weber
Loss of bone minerals and strength in rats with aldosteronism
Am J Physiol Heart Circ Physiol,
November 1, 2004;
287(5):
H2023 - H2026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Binkley, D. Krueger, C. S. Cowgill, L. Plum, E. Lake, K. E. Hansen, H. F. DeLuca, and M. K. Drezner
Assay Variation Confounds the Diagnosis of Hypovitaminosis D: A Call for Standardization
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3152 - 3157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F Holick
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
Am. J. Clinical Nutrition,
March 1, 2004;
79(3):
362 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Robson
What happened to evidence in NICE guidance on heart failure?
BMJ,
October 18, 2003;
327(7420):
932 - 932.
[Full Text]
|
 |
|
|